29-04-2025
Ekincare raises strategic investment from pharma giant MSD
HYDERABAD: Integrated
digital health
startup
EkinCare
on Tuesday said it raised a strategic, undisclosed investment led by global healthcare giant MSD (more popularly known as Merck & Co Inc of USA) through MSD IDEA Studio Asia Pacific, which is an initiative by the MSD Global Health Innovation Fund (MGHIF).
The pre-Series-C funding round also saw participation from EkinCare's existing investor, HealthQuad, which is a venture capital fund focused on healthcare innovation.
The Hyderabad-based startup, which raised a total funding of $22 million since it was founded in 2015, said it plans to utilise the fresh capital to expand its cashless OPD network and enhance AI-powered analytics to drive better
preventive care
,
chronic disease management
, and employee wellness outcomes.
Since inception, EkinCare partnered with over 1,000 companies and built a network of over 40,000 healthcare providers across India.
'Healthcare in India is at a turning point. Lifestyle diseases are on the rise, demand for preventive care is growing, and digital solutions are becoming a necessity. This investment from MSD IDEA Studio, with continued support from HealthQuad, is a visionary step forward for us. Their expertise in medicines, vaccines, and digital health, combined with our AI-driven, customer-centric approach, will help us deliver seamless, personalised healthcare to millions,' said Kiran Kalakuntla, co-founder & CEO of EkinCare.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
2025 Top Trending local enterprise accounting software [Click Here]
Esseps
Learn More
Undo
The
healthtech startup
was set up in 2015 by Kiran Kalakuntla along with Srikanth Samudrala, co-founder & CTO, and Noel Coutinho, co-founder & CBO. The startup leverages AI, data analytics, and telemedicine to make preventive healthcare personalised and accessible.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
